Cabozantinib S-Malate vs Nivolumab

## Cabozantinib S-Malate vs Nivolumab: Overview

This comparison examines the pharmacological differences between **Cabozantinib S-Malate** and **Nivolumab**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

## Pharmacokinetics

**Half-life**: Cabozantinib S-Malate — N/A; Nivolumab — 27 days.

## Chemical Properties

**Type**: Cabozantinib S-Malate — Small molecule; Nivolumab — Antibody.